SynthesisJournal of robotic surgery2025
Comparison of perioperative outcomes and oncological efficacy between Da Vinci Si and Da Vinci Xi robotic systems in colorectal surgery: systematic review and meta-analysis of controlled trials.
Synthesis in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Reported device problems and patient outcomes in da Vinci robotic robotic gastric and upper-gastrointestinal procedures: an FDA MAUDE database analysis.Journal of robotic surgery · 2026Article
- Clinical applications of the da Vinci Single-Port robotic system for treatment of colorectal cancer: a narrative review.Annals of surgical treatment and research · 2026Review
- Comment on: Comparison of perioperative outcomes and oncological efficacy between Da Vinci Si and Da Vinci Xi robotic systems in colorectal surgery: systematic review and meta-analysis of controlled trials.Journal of robotic surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This systematic review and meta-analysis investigated the effectiveness of the two models of surgical robotics in performing colorectal surgery based on the difference in perioperative outcomes of the Da Vinci Si robotic system, the Da Vinci Xi robotic system, and the control group derived from a meta-analysis of controlled trials. The electronic databases of PubMed, EMBASE, Google Scholar, and the Web of Science were searched widely in order to identify a total number of randomized controlled trials (RCTs) as well as cohort studies on colorectal cancer procedures using the Da Vinci Si and Xi systems. Random effect analysis for data was done using Review Manager 5.4. The metric data were analyzed according to the weighted mean difference (WMD) and nominal or ordinal data were analyzed according to odds ratios (OR) and 95% confidence intervals (CI). This meta-analysis incorporated data from eight comparative studies involving 1,000 patients undergoing robotic colorectal surgery, with 468 cases utilizing the Da Vinci Xi system and 532 cases using the Da Vinci Si system. Comparative analysis revealed statistically significant advantages for the Xi platform in three key perioperative parameters: operative time demonstrated a weighted mean difference (WMD) of -26.89 min (95% CI -53.43 to -0.36; P = 0.047), docking time showed a WMD of -4.18 min (95% CI -6.23 to -2.12; P < 0.001), and hospitalization duration was reduced by 0.98 days (95% CI -1.92 to -0.03; P = 0.043). Notably, the two systems exhibited comparable performance metrics with no statistically significant differences in several critical outcomes: intraoperative blood loss (P = 0.32), transfusion rates (P = 0.45), conversion rates (P = 0.78), overall postoperative complications (P = 0.61), and console operation time (P = 0.15). The analysis found no evidence of inherent technical superiority between the platforms when considering the comprehensive spectrum of surgical outcomes. The Da Vinci Xi system is safe to use and enhances operating room efficiency compared to the Da Vinci Si, while providing comparable safety and oncological outcomes. In light of these findings, future large-scale studies are warranted to further evaluate the clinical outcomes and cost-effectiveness of these robotic platforms in colorectal cancer surgery.
Indexed as
Identifiers
40580391What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.